MiR-186 targets ROCK1 to suppress the growth and metastasis of NSCLC cells

被引:67
|
作者
Cui, Guanghui [1 ]
Cui, Mingwei [2 ]
Li, Yuhang [1 ]
Liang, Youguang [1 ]
Li, Weihao [1 ]
Guo, Haizhou [1 ]
Zhao, Song [1 ]
机构
[1] Zhengzhou Univ, Affiliated Hosp 1, Dept Thorac Surg, Zhengzhou 450000, Peoples R China
[2] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Beijing 100191, Peoples R China
关键词
NSCLC; miR-186; ROCK1; Proliferation; Migration; Invasion; LUNG-CANCER CELLS; TO-MESENCHYMAL TRANSITION; DOWN-REGULATION; GASTRIC-CANCER; INVASION; PROMOTES; PROLIFERATION; EXPRESSION; MIGRATION; MOTILITY;
D O I
10.1007/s13277-014-2168-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MicroRNAs (miRNAs) act as oncogenes or tumor suppressors in human cancers. Increasing evidence shows that deregulation of miRNAs contributes to the development and progression of human non-small cell lung cancer (NSCLC). Here, we identified miR-186 as a tumor suppressor in NSCLC, which was decreased in NSCLC. Overexpression of miR-186 significantly inhibited proliferation, migration, and invasion of NSCLC cells. In addition, Rho-associated protein kinase 1 (ROCK1) was identified as a target of miR-186 in NSCLC cells. Restoration of ROCK1 remarkably reversed the tumor-suppressive effects of miR-186 on cell proliferation, migration, and invasion in NSCLC cells. Furthermore, ROCK1 was inversely correlated with miR-186 expression in NSCLC. Collectively, our data indicate that miR-186 functions as tumor suppressor in NSCLC by targeting ROCK1.
引用
收藏
页码:8933 / 8937
页数:5
相关论文
共 50 条
  • [41] MiR-654-3p targets SRC to suppress tumor growth in non-small cell lung cancer
    Pang, Min
    Jiang, Yongjie
    Huang, Yuyan
    Ren, Bi
    He, Liping
    Jiang, Li
    CELLULAR AND MOLECULAR BIOLOGY, 2023, 69 (04) : 157 - 163
  • [42] Circ-PAX2 promotes proliferation and metastasis by absorbing miR-186 in lung cancer cells
    Wang, Lei
    Xu, Cong
    Wang, Chenghai
    Gong, Weijuan
    Zhang, Kefan
    Chen, Qiuyue
    Zhou, Shishi
    Qi, Tingyue
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2018, 11 (07): : 3793 - +
  • [43] MicroRNA-145 inhibits proliferation and promotes apoptosis of HepG2 cells by targeting ROCK1 through the ROCK1/NF-κB signaling pathway
    Wang, R. -K.
    Shao, X. -M.
    Yang, J. -P.
    Yan, H. -L.
    Shao, Y.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (07) : 2777 - 2785
  • [44] Knocking down miR-384 promotes growth and metastasis of osteosarcoma MG63 cells by targeting SLBP
    Wang, Yang
    Huang, Hong
    Li, Yi
    ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2019, 47 (01) : 1458 - 1465
  • [45] MicroRNA-342 targets Cofilin 1 to suppress the growth, migration and invasion of human breast cancer cells
    Liu, Cong
    Xing, Hua
    Luo, Xiao
    Wang, Yimin
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2020, 687
  • [46] miR-194 targets RBX1 gene to modulate proliferation and migration of gastric cancer cells
    Chen, Xiaonan
    Wang, Yuanyuan
    Zang, Wenqiao
    Du, Yuwen
    Li, Min
    Zhao, Guoqiang
    TUMOR BIOLOGY, 2015, 36 (04) : 2393 - 2401
  • [47] MiR-202 inhibits cell proliferation, invasion, and migration in breast cancer by targeting ROCK1 gene
    Xu, Fangfang
    Li, Hui
    Hu, Chengjiu
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 120 (09) : 16008 - 16018
  • [48] ROCK1, a novel target of miR-145, promotes glioma cell invasion
    Wan, Xin
    Cheng, Quan
    Peng, Renjun
    Ma, Zhiming
    Chen, Zigui
    Cao, Yiqiang
    Jiang, Bing
    MOLECULAR MEDICINE REPORTS, 2014, 9 (05) : 1877 - 1882
  • [49] Neferine inhibits MDA-MB-231 cells growth and metastasis by regulating miR-374a/FGFR-2
    Liu, Zhisheng
    Zhang, Shenglin
    Wang, Tingting
    Shao, Hui
    Gao, Junjie
    Wang, Ye
    Ge, Yunjie
    CHEMICO-BIOLOGICAL INTERACTIONS, 2019, 309
  • [50] miR-144 inhibits growth and metastasis of cervical cancer cells by targeting VEGFA and VEGFC
    Tao, Pingping
    Wen, Hao
    Yang, Binlie
    Zhang, Ai
    Wu, Xiaohua
    Li, Qing
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2018, 15 (01) : 562 - 568